trial · primary record
AHB-137
Chronic Hepatitis B
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 105 |
| Primary completion | 2029-06-20 |
| Primary endpoint | Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) in Phase I |
| Registry ID | NCT07897448 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:53.355Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897448
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.